Monopar Therapeutics
MNPR
#8861
Rank
S$0.12 B
Marketcap
$23.11
Share price
3.54%
Change (1 day)
989.30%
Change (1 year)

Monopar Therapeutics (MNPR) - Cash on Hand

Cash on Hand as of June 2024 : S$9.53 Million

According to Monopar Therapeutics's latest financial reports the company has S$9.53 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Monopar Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$17.58 M-35.92%
2021-12-31S$27.44 M23.97%
2020-12-31S$22.14 M24.29%
2019-12-31S$17.81 M89.19%
2018-12-31S$9.41 M-21.62%
2017-12-31S$12.01 M300.48%
2016-12-31S$2.99 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.38 B 3,923.25%๐Ÿ‡บ๐Ÿ‡ธ USA